You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

conditioning regimen, melphalan, busulfan, fludarabine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Disease-free Survival Trial in Shanghai (MBF-RIC)

Recruiting
  • Disease-free Survival
  • Shanghai, Shanghai, China
  • +1 more
Jun 28, 2022

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023

Lymphoid Tumor Trial in Shanghai (Flu-Bu-Mel-E)

Recruiting
  • Lymphoid Neoplasm
  • Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 22, 2021

Refractory Acute Myeloid Leukemia Trial in Shanghai (Aza-Ven-allo-HSCT)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Shanghai, China
  • +2 more
May 27, 2021

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 14, 2022

Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Stem Cell Transplantation
  • busulfan, cyclophosphamide and melphalan, BuCyMel
  • clofarabine, fludarabine and busulfan, CloFluBu
  • Brussels, Belgium
  • +16 more
Jul 25, 2022

Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

Recruiting
  • Cytarabine+Thiotepa + Fludarabine + Busulfan
  • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • cytarabine+thiotepa+ fludarabine + busulfan
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 26, 2022

Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

Not yet recruiting
  • Acute Myeloid Leukemia
  • MCBC regimen
  • Bu/Cy regimen
  • (no location specified)
Nov 13, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

      Not yet recruiting
      • Severe Aplastic Anemia
      • (no location specified)
      Oct 1, 2023

      Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

      Recruiting
      • Acute Leukemia
      • mitoxantrone liposome
      • ATG
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Feb 13, 2023

      Multiple Myeloma Trial in Hackensack (Fludarabine monophosphate, melphalan, Bortezomib)

      Completed
      Has Results
      • Multiple Myeloma
      • Fludarabine monophosphate, melphalan, Bortezomib
      • Hackensack, New Jersey
        John Theurer Cancer Center at Hackensack University Medical Cent
      Apr 29, 2022

      Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)

      Recruiting
      • Hematological Malignancy
      • Multiple Myeloma
      • Milwaukee, Wisconsin
        Froedtert Hospital & the Medical College of Wisconsin
      Oct 4, 2022

      Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

      Recruiting
      • Leukemia, Acute Lymphoblastic
      • +5 more
      • Saint Petersburg, Russian Federation
        RM Gorbacheva Research Institute
      Jul 19, 2022

      Non Malignant Diseases, Immunodeficiencies, Hemoglobinopathies Trial in Philadelphia (RIC: Distal Campath, RIC:Intermediate

      Recruiting
      • Non Malignant Diseases
      • +2 more
      • RIC: Distal Campath
      • +2 more
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Mar 8, 2022

      Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

      Recruiting
      • Lymphoma
      • BEAM Protocol
      • CEM protocol
      • Cairo, Egypt
        International Medical Center (IMC) Hospital, Cairo, Egypt.
      Apr 1, 2023

      Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

      Completed
      • Multiple Myeloma
      • Edmonton, Alberta, Canada
      • +9 more
      Sep 20, 2022

      Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

      Recruiting
      • Acute Myeloid Leukemia
      • Pediatric Cancer
      • Boston, Massachusetts
      • +1 more
      Oct 24, 2022

      Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

      Recruiting
      • Myelodysplastic Syndrome
      • +2 more
      • Granulocyte Colony-Stimulating Factor(G-CSF)
      • +5 more
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      Jul 11, 2022

      Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +17 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center & Research Institute
      Jan 10, 2023